EUVIMEDEUVIMED entdecken
Crossref

p200CUX1-regulated BMP8B inhibits the progression of acute myeloid leukemia via the MAPK signaling pathway

Meng Wang, Liang Zhong, Hongyan Zhang, Peng Wan, Xuan Chu, Xin Shao, Shuyu Chen, Ziwei Zhou, Lihua Yu, Beizhong Liu

Medical Oncology · 2024

DOI: 10.1007/s12032-024-02398-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Oncology, 2024. Verfasst von Meng Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Central Laboratory of Yongchuan Hospital, Chongqing Medical University, Chongqing, 402160, China. Hauptthemen laut MEDLINE: Bone Morphogenetic Proteins, Leukemia, Myeloid, Acute, MAP Kinase Signaling System. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Key Technology Innovation Special of Key Industries of the Chongqing Science and Technology Bureau, Joint Medical Research Project of Chongqing Municipal Science and Technology Commission and Health Commission, Chongqing Education Commission Science and Technology Research Program Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The full-length p200CUX1 protein encoded by the homology frame CUT-like protein (CUX1) plays an important role in tumors as a pro-oncogene or oncogene. However, its role and mechanism in acute myeloid leukemia remain unknown. p200CUX1 regulates several pathways, including the MAPK signaling pathway. Our data showed that p200CUX1 is lowly expressed in THP1 and U937 AML cell lines. Lentiviral overexpression of p200CUX1 reduced proliferation and promoted apoptosis and G0/G1 phase blockade, correlating with MAPK pathway suppression. Additionally, p200CUX1 regulated the expression of bone morphogenetic protein 8B (BMP8B), which is overexpressed in AML. Overexpression of p200CUX1 downregulated BMP8B expression and inhibited the MAPK pathway. Furthermore, BMP8B knockdown inhibited AML cell proliferation, enhanced apoptosis and the sensitivity of ATRA-induced cell differentiation, and blocked G0/G1 transition. Our findings demonstrate the pivotal function of the p200CUX1-BMP8B-MAPK axis in maintaining the viability of AML cells. Consequently, targeting p200CUX1 could represent a viable strategy in AML therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone Morphogenetic ProteinsLeukemia, Myeloid, AcuteMAP Kinase Signaling SystemHumansApoptosisCell Line, TumorCell ProliferationDisease ProgressionRepressor ProteinsTranscription FactorsHomeodomain Proteins

Stichwörter der Autor:innen

Acute myeloid leukemiaBMP8BDifferentiationMAPKProliferationp200CUX1

Substanzen

Bone Morphogenetic ProteinsRepressor ProteinsCUX1 protein, humanBMP8B protein, humanTranscription FactorsHomeodomain Proteins

Autor:innen und Institutionen

  • Central Laboratory of Yongchuan Hospital, Chongqing Medical University, Chongqing, 402160, China.
  • Key Laboratory of Laboratory Medical Diagnostics, Ministry of Education, Department of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, China.
  • Clinical Laboratory of Yongchuan Hospital, Chongqing Medical University, Chongqing, 402160, China. yulihuacool@163.com.
  • Central Laboratory of Yongchuan Hospital, Chongqing Medical University, Chongqing, 402160, China. liubeizhong@cqmu.edu.cn.
  • Key Laboratory of Laboratory Medical Diagnostics, Ministry of Education, Department of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, China. liubeizhong@cqmu.edu.cn.

Förderung

  • Key Technology Innovation Special of Key Industries of the Chongqing Science and Technology Bureau
  • Joint Medical Research Project of Chongqing Municipal Science and Technology Commission and Health Commission
  • Chongqing Education Commission Science and Technology Research Program Project
  • Chongqing Natural Science Foundation Project

Zitieren

APA

Wang, M., Zhong, L., Zhang, H., Wan, P., Chu, X., Shao, X., Chen, S., Zhou, Z., Yu, L., & Liu, B. (2024). p200CUX1-regulated BMP8B inhibits the progression of acute myeloid leukemia via the MAPK signaling pathway. Medical Oncology. https://doi.org/10.1007/s12032-024-02398-2

Vancouver

Wang M, Zhong L, Zhang H, Wan P, Chu X, Shao X, et al. p200CUX1-regulated BMP8B inhibits the progression of acute myeloid leukemia via the MAPK signaling pathway. Medical Oncology. 2024. doi:10.1007/s12032-024-02398-2

BibTeX
@article{Wang2024,
  author = {Wang, Meng and Zhong, Liang and Zhang, Hongyan and Wan, Peng and Chu, Xuan and Shao, Xin and Chen, Shuyu and Zhou, Ziwei and Yu, Lihua and Liu, Beizhong},
  title = {p200CUX1-regulated BMP8B inhibits the progression of acute myeloid leukemia via the MAPK signaling pathway},
  journal = {Medical Oncology},
  year = {2024},
  doi = {10.1007/s12032-024-02398-2}
}
Kostenlos starten →